nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalbuphine—Morphine—UGT2B7—urinary bladder cancer	0.0167	0.719	CrCbGaD
Nalbuphine—Naloxone—ESR1—urinary bladder cancer	0.00651	0.281	CrCbGaD
Nalbuphine—Sweating increased—Cisplatin—urinary bladder cancer	0.00409	0.00419	CcSEcCtD
Nalbuphine—Feeling hot—Doxorubicin—urinary bladder cancer	0.00405	0.00415	CcSEcCtD
Nalbuphine—Cramp muscle—Etoposide—urinary bladder cancer	0.00401	0.0041	CcSEcCtD
Nalbuphine—Dizziness—Mitomycin—urinary bladder cancer	0.00401	0.0041	CcSEcCtD
Nalbuphine—Vomiting—Mitomycin—urinary bladder cancer	0.00385	0.00394	CcSEcCtD
Nalbuphine—Rash—Mitomycin—urinary bladder cancer	0.00382	0.00391	CcSEcCtD
Nalbuphine—Dermatitis—Mitomycin—urinary bladder cancer	0.00382	0.00391	CcSEcCtD
Nalbuphine—Headache—Mitomycin—urinary bladder cancer	0.0038	0.00389	CcSEcCtD
Nalbuphine—Bronchospasm—Etoposide—urinary bladder cancer	0.00379	0.00388	CcSEcCtD
Nalbuphine—Sweating increased—Etoposide—urinary bladder cancer	0.00375	0.00384	CcSEcCtD
Nalbuphine—Erythema—Thiotepa—urinary bladder cancer	0.00373	0.00382	CcSEcCtD
Nalbuphine—Tension—Thiotepa—urinary bladder cancer	0.00366	0.00375	CcSEcCtD
Nalbuphine—Nervousness—Thiotepa—urinary bladder cancer	0.00363	0.00371	CcSEcCtD
Nalbuphine—Nausea—Mitomycin—urinary bladder cancer	0.0036	0.00368	CcSEcCtD
Nalbuphine—Hypoaesthesia—Fluorouracil—urinary bladder cancer	0.00353	0.00361	CcSEcCtD
Nalbuphine—Vision blurred—Thiotepa—urinary bladder cancer	0.00352	0.0036	CcSEcCtD
Nalbuphine—Agitation—Thiotepa—urinary bladder cancer	0.00343	0.00351	CcSEcCtD
Nalbuphine—Bradycardia—Cisplatin—urinary bladder cancer	0.00342	0.0035	CcSEcCtD
Nalbuphine—Injection site reaction—Epirubicin—urinary bladder cancer	0.00342	0.0035	CcSEcCtD
Nalbuphine—Pulmonary oedema—Methotrexate—urinary bladder cancer	0.00327	0.00335	CcSEcCtD
Nalbuphine—Convulsion—Thiotepa—urinary bladder cancer	0.00323	0.00331	CcSEcCtD
Nalbuphine—Hypertension—Thiotepa—urinary bladder cancer	0.00322	0.0033	CcSEcCtD
Nalbuphine—Anxiety—Thiotepa—urinary bladder cancer	0.00317	0.00324	CcSEcCtD
Nalbuphine—Injection site reaction—Doxorubicin—urinary bladder cancer	0.00316	0.00324	CcSEcCtD
Nalbuphine—Erythema—Gemcitabine—urinary bladder cancer	0.00314	0.00321	CcSEcCtD
Nalbuphine—Flushing—Cisplatin—urinary bladder cancer	0.00312	0.00319	CcSEcCtD
Nalbuphine—Erythema—Fluorouracil—urinary bladder cancer	0.00309	0.00316	CcSEcCtD
Nalbuphine—Confusional state—Thiotepa—urinary bladder cancer	0.00307	0.00314	CcSEcCtD
Nalbuphine—Hypoaesthesia—Etoposide—urinary bladder cancer	0.00306	0.00314	CcSEcCtD
Nalbuphine—Pulmonary oedema—Epirubicin—urinary bladder cancer	0.00306	0.00313	CcSEcCtD
Nalbuphine—Tachycardia—Thiotepa—urinary bladder cancer	0.00297	0.00304	CcSEcCtD
Nalbuphine—Erythema—Cisplatin—urinary bladder cancer	0.00293	0.003	CcSEcCtD
Nalbuphine—Vision blurred—Fluorouracil—urinary bladder cancer	0.00291	0.00298	CcSEcCtD
Nalbuphine—Flushing—Etoposide—urinary bladder cancer	0.00286	0.00293	CcSEcCtD
Nalbuphine—Pulmonary oedema—Doxorubicin—urinary bladder cancer	0.00283	0.0029	CcSEcCtD
Nalbuphine—Muscle spasms—Cisplatin—urinary bladder cancer	0.00281	0.00288	CcSEcCtD
Nalbuphine—Vision blurred—Cisplatin—urinary bladder cancer	0.00276	0.00282	CcSEcCtD
Nalbuphine—Tremor—Cisplatin—urinary bladder cancer	0.00274	0.00281	CcSEcCtD
Nalbuphine—Paraesthesia—Thiotepa—urinary bladder cancer	0.00274	0.0028	CcSEcCtD
Nalbuphine—Hypertension—Gemcitabine—urinary bladder cancer	0.00271	0.00278	CcSEcCtD
Nalbuphine—Somnolence—Thiotepa—urinary bladder cancer	0.00271	0.00277	CcSEcCtD
Nalbuphine—Dyspepsia—Thiotepa—urinary bladder cancer	0.00268	0.00275	CcSEcCtD
Nalbuphine—Convulsion—Fluorouracil—urinary bladder cancer	0.00268	0.00274	CcSEcCtD
Nalbuphine—Dysgeusia—Etoposide—urinary bladder cancer	0.00263	0.00269	CcSEcCtD
Nalbuphine—Muscle spasms—Etoposide—urinary bladder cancer	0.00258	0.00264	CcSEcCtD
Nalbuphine—Oedema—Gemcitabine—urinary bladder cancer	0.00256	0.00262	CcSEcCtD
Nalbuphine—Confusional state—Fluorouracil—urinary bladder cancer	0.00254	0.0026	CcSEcCtD
Nalbuphine—Convulsion—Cisplatin—urinary bladder cancer	0.00254	0.0026	CcSEcCtD
Nalbuphine—Oedema—Fluorouracil—urinary bladder cancer	0.00252	0.00258	CcSEcCtD
Nalbuphine—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00251	0.00257	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00249	0.00255	CcSEcCtD
Nalbuphine—Anxiety—Cisplatin—urinary bladder cancer	0.00248	0.00254	CcSEcCtD
Nalbuphine—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.00248	0.00254	CcSEcCtD
Nalbuphine—Tachycardia—Fluorouracil—urinary bladder cancer	0.00246	0.00252	CcSEcCtD
Nalbuphine—Urticaria—Thiotepa—urinary bladder cancer	0.00242	0.00248	CcSEcCtD
Nalbuphine—Vertigo—Etoposide—urinary bladder cancer	0.00241	0.00247	CcSEcCtD
Nalbuphine—Body temperature increased—Thiotepa—urinary bladder cancer	0.00241	0.00247	CcSEcCtD
Nalbuphine—Abdominal pain—Thiotepa—urinary bladder cancer	0.00241	0.00247	CcSEcCtD
Nalbuphine—Hypotension—Gemcitabine—urinary bladder cancer	0.00239	0.00245	CcSEcCtD
Nalbuphine—Oedema—Cisplatin—urinary bladder cancer	0.00239	0.00245	CcSEcCtD
Nalbuphine—Cardiac arrest—Epirubicin—urinary bladder cancer	0.00237	0.00243	CcSEcCtD
Nalbuphine—Loss of consciousness—Etoposide—urinary bladder cancer	0.00236	0.00241	CcSEcCtD
Nalbuphine—Hypotension—Fluorouracil—urinary bladder cancer	0.00235	0.00241	CcSEcCtD
Nalbuphine—Tachycardia—Cisplatin—urinary bladder cancer	0.00233	0.00239	CcSEcCtD
Nalbuphine—Convulsion—Etoposide—urinary bladder cancer	0.00232	0.00238	CcSEcCtD
Nalbuphine—Hypertension—Etoposide—urinary bladder cancer	0.00232	0.00237	CcSEcCtD
Nalbuphine—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00231	0.00236	CcSEcCtD
Nalbuphine—Asthma—Methotrexate—urinary bladder cancer	0.00231	0.00236	CcSEcCtD
Nalbuphine—Paraesthesia—Gemcitabine—urinary bladder cancer	0.0023	0.00236	CcSEcCtD
Nalbuphine—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00228	0.00234	CcSEcCtD
Nalbuphine—Somnolence—Gemcitabine—urinary bladder cancer	0.00228	0.00233	CcSEcCtD
Nalbuphine—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00226	0.00232	CcSEcCtD
Nalbuphine—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00225	0.0023	CcSEcCtD
Nalbuphine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00224	0.0023	CcSEcCtD
Nalbuphine—Somnolence—Fluorouracil—urinary bladder cancer	0.00224	0.00229	CcSEcCtD
Nalbuphine—Hypotension—Cisplatin—urinary bladder cancer	0.00223	0.00229	CcSEcCtD
Nalbuphine—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00222	0.00227	CcSEcCtD
Nalbuphine—Confusional state—Etoposide—urinary bladder cancer	0.00221	0.00226	CcSEcCtD
Nalbuphine—Cardiac arrest—Doxorubicin—urinary bladder cancer	0.0022	0.00225	CcSEcCtD
Nalbuphine—Asthenia—Thiotepa—urinary bladder cancer	0.00219	0.00224	CcSEcCtD
Nalbuphine—Asthma—Epirubicin—urinary bladder cancer	0.00216	0.00221	CcSEcCtD
Nalbuphine—Pruritus—Thiotepa—urinary bladder cancer	0.00216	0.00221	CcSEcCtD
Nalbuphine—Paraesthesia—Cisplatin—urinary bladder cancer	0.00214	0.0022	CcSEcCtD
Nalbuphine—Tachycardia—Etoposide—urinary bladder cancer	0.00214	0.00219	CcSEcCtD
Nalbuphine—Dyspnoea—Cisplatin—urinary bladder cancer	0.00213	0.00218	CcSEcCtD
Nalbuphine—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00212	0.00217	CcSEcCtD
Nalbuphine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00211	0.00216	CcSEcCtD
Nalbuphine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00208	0.00213	CcSEcCtD
Nalbuphine—Depression—Methotrexate—urinary bladder cancer	0.00205	0.0021	CcSEcCtD
Nalbuphine—Hypotension—Etoposide—urinary bladder cancer	0.00204	0.00209	CcSEcCtD
Nalbuphine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00203	0.00207	CcSEcCtD
Nalbuphine—Dizziness—Thiotepa—urinary bladder cancer	0.00201	0.00206	CcSEcCtD
Nalbuphine—Urticaria—Fluorouracil—urinary bladder cancer	0.002	0.00205	CcSEcCtD
Nalbuphine—Asthma—Doxorubicin—urinary bladder cancer	0.002	0.00204	CcSEcCtD
Nalbuphine—Pollakiuria—Epirubicin—urinary bladder cancer	0.00199	0.00204	CcSEcCtD
Nalbuphine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00199	0.00204	CcSEcCtD
Nalbuphine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00197	0.00202	CcSEcCtD
Nalbuphine—Paraesthesia—Etoposide—urinary bladder cancer	0.00197	0.00201	CcSEcCtD
Nalbuphine—Dyspnoea—Etoposide—urinary bladder cancer	0.00195	0.002	CcSEcCtD
Nalbuphine—Somnolence—Etoposide—urinary bladder cancer	0.00195	0.00199	CcSEcCtD
Nalbuphine—Vomiting—Thiotepa—urinary bladder cancer	0.00194	0.00198	CcSEcCtD
Nalbuphine—Rash—Thiotepa—urinary bladder cancer	0.00192	0.00197	CcSEcCtD
Nalbuphine—Dermatitis—Thiotepa—urinary bladder cancer	0.00192	0.00196	CcSEcCtD
Nalbuphine—Headache—Thiotepa—urinary bladder cancer	0.00191	0.00195	CcSEcCtD
Nalbuphine—Body temperature increased—Cisplatin—urinary bladder cancer	0.00189	0.00193	CcSEcCtD
Nalbuphine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00186	0.0019	CcSEcCtD
Nalbuphine—Pollakiuria—Doxorubicin—urinary bladder cancer	0.00184	0.00189	CcSEcCtD
Nalbuphine—Asthenia—Gemcitabine—urinary bladder cancer	0.00184	0.00188	CcSEcCtD
Nalbuphine—Pruritus—Gemcitabine—urinary bladder cancer	0.00181	0.00186	CcSEcCtD
Nalbuphine—Nausea—Thiotepa—urinary bladder cancer	0.00181	0.00185	CcSEcCtD
Nalbuphine—Feeling abnormal—Etoposide—urinary bladder cancer	0.0018	0.00185	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00179	0.00183	CcSEcCtD
Nalbuphine—Pruritus—Fluorouracil—urinary bladder cancer	0.00178	0.00183	CcSEcCtD
Nalbuphine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00176	0.0018	CcSEcCtD
Nalbuphine—Bradycardia—Epirubicin—urinary bladder cancer	0.00176	0.0018	CcSEcCtD
Nalbuphine—Urticaria—Etoposide—urinary bladder cancer	0.00174	0.00178	CcSEcCtD
Nalbuphine—Body temperature increased—Etoposide—urinary bladder cancer	0.00173	0.00177	CcSEcCtD
Nalbuphine—Abdominal pain—Etoposide—urinary bladder cancer	0.00173	0.00177	CcSEcCtD
Nalbuphine—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.00172	0.00176	CcSEcCtD
Nalbuphine—Asthenia—Cisplatin—urinary bladder cancer	0.00171	0.00175	CcSEcCtD
Nalbuphine—Dizziness—Fluorouracil—urinary bladder cancer	0.00167	0.00171	CcSEcCtD
Nalbuphine—Vomiting—Gemcitabine—urinary bladder cancer	0.00163	0.00167	CcSEcCtD
Nalbuphine—Bradycardia—Doxorubicin—urinary bladder cancer	0.00163	0.00167	CcSEcCtD
Nalbuphine—Rash—Gemcitabine—urinary bladder cancer	0.00162	0.00165	CcSEcCtD
Nalbuphine—Dermatitis—Gemcitabine—urinary bladder cancer	0.00161	0.00165	CcSEcCtD
Nalbuphine—Hypersensitivity—Etoposide—urinary bladder cancer	0.00161	0.00165	CcSEcCtD
Nalbuphine—Erythema—Methotrexate—urinary bladder cancer	0.00161	0.00164	CcSEcCtD
Nalbuphine—Headache—Gemcitabine—urinary bladder cancer	0.00161	0.00164	CcSEcCtD
Nalbuphine—Flushing—Epirubicin—urinary bladder cancer	0.0016	0.00164	CcSEcCtD
Nalbuphine—Vomiting—Fluorouracil—urinary bladder cancer	0.0016	0.00164	CcSEcCtD
Nalbuphine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.00159	0.00163	CcSEcCtD
Nalbuphine—Rash—Fluorouracil—urinary bladder cancer	0.00159	0.00163	CcSEcCtD
Nalbuphine—Dermatitis—Fluorouracil—urinary bladder cancer	0.00159	0.00162	CcSEcCtD
Nalbuphine—Headache—Fluorouracil—urinary bladder cancer	0.00158	0.00162	CcSEcCtD
Nalbuphine—Dysgeusia—Methotrexate—urinary bladder cancer	0.00157	0.00161	CcSEcCtD
Nalbuphine—Asthenia—Etoposide—urinary bladder cancer	0.00157	0.00161	CcSEcCtD
Nalbuphine—Pruritus—Etoposide—urinary bladder cancer	0.00155	0.00159	CcSEcCtD
Nalbuphine—Nausea—Gemcitabine—urinary bladder cancer	0.00152	0.00156	CcSEcCtD
Nalbuphine—Vomiting—Cisplatin—urinary bladder cancer	0.00152	0.00155	CcSEcCtD
Nalbuphine—Vision blurred—Methotrexate—urinary bladder cancer	0.00151	0.00155	CcSEcCtD
Nalbuphine—Rash—Cisplatin—urinary bladder cancer	0.00151	0.00154	CcSEcCtD
Nalbuphine—Dermatitis—Cisplatin—urinary bladder cancer	0.0015	0.00154	CcSEcCtD
Nalbuphine—Erythema—Epirubicin—urinary bladder cancer	0.0015	0.00154	CcSEcCtD
Nalbuphine—Nausea—Fluorouracil—urinary bladder cancer	0.0015	0.00153	CcSEcCtD
Nalbuphine—Flushing—Doxorubicin—urinary bladder cancer	0.00148	0.00152	CcSEcCtD
Nalbuphine—Tension—Epirubicin—urinary bladder cancer	0.00147	0.00151	CcSEcCtD
Nalbuphine—Dysgeusia—Epirubicin—urinary bladder cancer	0.00147	0.00151	CcSEcCtD
Nalbuphine—Nervousness—Epirubicin—urinary bladder cancer	0.00146	0.00149	CcSEcCtD
Nalbuphine—Dizziness—Etoposide—urinary bladder cancer	0.00145	0.00148	CcSEcCtD
Nalbuphine—Muscle spasms—Epirubicin—urinary bladder cancer	0.00145	0.00148	CcSEcCtD
Nalbuphine—Vertigo—Methotrexate—urinary bladder cancer	0.00144	0.00148	CcSEcCtD
Nalbuphine—Nausea—Cisplatin—urinary bladder cancer	0.00142	0.00145	CcSEcCtD
Nalbuphine—Vision blurred—Epirubicin—urinary bladder cancer	0.00142	0.00145	CcSEcCtD
Nalbuphine—Convulsion—Methotrexate—urinary bladder cancer	0.00139	0.00142	CcSEcCtD
Nalbuphine—Vomiting—Etoposide—urinary bladder cancer	0.00139	0.00142	CcSEcCtD
Nalbuphine—Erythema—Doxorubicin—urinary bladder cancer	0.00139	0.00142	CcSEcCtD
Nalbuphine—Agitation—Epirubicin—urinary bladder cancer	0.00138	0.00141	CcSEcCtD
Nalbuphine—Rash—Etoposide—urinary bladder cancer	0.00138	0.00141	CcSEcCtD
Nalbuphine—Dermatitis—Etoposide—urinary bladder cancer	0.00138	0.00141	CcSEcCtD
Nalbuphine—Headache—Etoposide—urinary bladder cancer	0.00137	0.0014	CcSEcCtD
Nalbuphine—Tension—Doxorubicin—urinary bladder cancer	0.00136	0.0014	CcSEcCtD
Nalbuphine—Dysgeusia—Doxorubicin—urinary bladder cancer	0.00136	0.00139	CcSEcCtD
Nalbuphine—Nervousness—Doxorubicin—urinary bladder cancer	0.00135	0.00138	CcSEcCtD
Nalbuphine—Vertigo—Epirubicin—urinary bladder cancer	0.00135	0.00138	CcSEcCtD
Nalbuphine—Syncope—Epirubicin—urinary bladder cancer	0.00135	0.00138	CcSEcCtD
Nalbuphine—Muscle spasms—Doxorubicin—urinary bladder cancer	0.00134	0.00137	CcSEcCtD
Nalbuphine—Confusional state—Methotrexate—urinary bladder cancer	0.00132	0.00135	CcSEcCtD
Nalbuphine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.00132	0.00135	CcSEcCtD
Nalbuphine—Vision blurred—Doxorubicin—urinary bladder cancer	0.00131	0.00134	CcSEcCtD
Nalbuphine—Convulsion—Epirubicin—urinary bladder cancer	0.0013	0.00133	CcSEcCtD
Nalbuphine—Nausea—Etoposide—urinary bladder cancer	0.0013	0.00133	CcSEcCtD
Nalbuphine—Hypertension—Epirubicin—urinary bladder cancer	0.0013	0.00133	CcSEcCtD
Nalbuphine—Agitation—Doxorubicin—urinary bladder cancer	0.00128	0.00131	CcSEcCtD
Nalbuphine—Anxiety—Epirubicin—urinary bladder cancer	0.00128	0.00131	CcSEcCtD
Nalbuphine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.00127	0.0013	CcSEcCtD
Nalbuphine—Dry mouth—Epirubicin—urinary bladder cancer	0.00125	0.00128	CcSEcCtD
Nalbuphine—Vertigo—Doxorubicin—urinary bladder cancer	0.00125	0.00128	CcSEcCtD
Nalbuphine—Syncope—Doxorubicin—urinary bladder cancer	0.00125	0.00128	CcSEcCtD
Nalbuphine—Confusional state—Epirubicin—urinary bladder cancer	0.00124	0.00127	CcSEcCtD
Nalbuphine—Oedema—Epirubicin—urinary bladder cancer	0.00123	0.00126	CcSEcCtD
Nalbuphine—Hypotension—Methotrexate—urinary bladder cancer	0.00122	0.00125	CcSEcCtD
Nalbuphine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.00122	0.00125	CcSEcCtD
Nalbuphine—Shock—Epirubicin—urinary bladder cancer	0.00121	0.00124	CcSEcCtD
Nalbuphine—Convulsion—Doxorubicin—urinary bladder cancer	0.0012	0.00123	CcSEcCtD
Nalbuphine—Hypertension—Doxorubicin—urinary bladder cancer	0.0012	0.00123	CcSEcCtD
Nalbuphine—Tachycardia—Epirubicin—urinary bladder cancer	0.0012	0.00123	CcSEcCtD
Nalbuphine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.00119	0.00121	CcSEcCtD
Nalbuphine—Anxiety—Doxorubicin—urinary bladder cancer	0.00118	0.00121	CcSEcCtD
Nalbuphine—Paraesthesia—Methotrexate—urinary bladder cancer	0.00118	0.0012	CcSEcCtD
Nalbuphine—Dyspnoea—Methotrexate—urinary bladder cancer	0.00117	0.0012	CcSEcCtD
Nalbuphine—Somnolence—Methotrexate—urinary bladder cancer	0.00117	0.00119	CcSEcCtD
Nalbuphine—Dry mouth—Doxorubicin—urinary bladder cancer	0.00116	0.00119	CcSEcCtD
Nalbuphine—Dyspepsia—Methotrexate—urinary bladder cancer	0.00115	0.00118	CcSEcCtD
Nalbuphine—Hypotension—Epirubicin—urinary bladder cancer	0.00115	0.00117	CcSEcCtD
Nalbuphine—Confusional state—Doxorubicin—urinary bladder cancer	0.00114	0.00117	CcSEcCtD
Nalbuphine—Oedema—Doxorubicin—urinary bladder cancer	0.00114	0.00116	CcSEcCtD
Nalbuphine—Shock—Doxorubicin—urinary bladder cancer	0.00112	0.00114	CcSEcCtD
Nalbuphine—Tachycardia—Doxorubicin—urinary bladder cancer	0.00111	0.00113	CcSEcCtD
Nalbuphine—Paraesthesia—Epirubicin—urinary bladder cancer	0.0011	0.00113	CcSEcCtD
Nalbuphine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.0011	0.00112	CcSEcCtD
Nalbuphine—Dyspnoea—Epirubicin—urinary bladder cancer	0.00109	0.00112	CcSEcCtD
Nalbuphine—Somnolence—Epirubicin—urinary bladder cancer	0.00109	0.00112	CcSEcCtD
Nalbuphine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00108	0.00111	CcSEcCtD
Nalbuphine—Dyspepsia—Epirubicin—urinary bladder cancer	0.00108	0.00111	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.00107	0.0011	CcSEcCtD
Nalbuphine—Hypotension—Doxorubicin—urinary bladder cancer	0.00106	0.00109	CcSEcCtD
Nalbuphine—Urticaria—Methotrexate—urinary bladder cancer	0.00104	0.00107	CcSEcCtD
Nalbuphine—Abdominal pain—Methotrexate—urinary bladder cancer	0.00104	0.00106	CcSEcCtD
Nalbuphine—Body temperature increased—Methotrexate—urinary bladder cancer	0.00104	0.00106	CcSEcCtD
Nalbuphine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.00102	0.00104	CcSEcCtD
Nalbuphine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.00101	0.00104	CcSEcCtD
Nalbuphine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00101	0.00103	CcSEcCtD
Nalbuphine—Somnolence—Doxorubicin—urinary bladder cancer	0.00101	0.00103	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.001	0.00103	CcSEcCtD
Nalbuphine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000999	0.00102	CcSEcCtD
Nalbuphine—Urticaria—Epirubicin—urinary bladder cancer	0.000975	0.000998	CcSEcCtD
Nalbuphine—Abdominal pain—Epirubicin—urinary bladder cancer	0.00097	0.000993	CcSEcCtD
Nalbuphine—Body temperature increased—Epirubicin—urinary bladder cancer	0.00097	0.000993	CcSEcCtD
Nalbuphine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000966	0.000989	CcSEcCtD
Nalbuphine—Asthenia—Methotrexate—urinary bladder cancer	0.00094	0.000963	CcSEcCtD
Nalbuphine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000935	0.000958	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000928	0.00095	CcSEcCtD
Nalbuphine—Pruritus—Methotrexate—urinary bladder cancer	0.000927	0.000949	CcSEcCtD
Nalbuphine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000904	0.000925	CcSEcCtD
Nalbuphine—Urticaria—Doxorubicin—urinary bladder cancer	0.000902	0.000923	CcSEcCtD
Nalbuphine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000897	0.000919	CcSEcCtD
Nalbuphine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000897	0.000919	CcSEcCtD
Nalbuphine—Asthenia—Epirubicin—urinary bladder cancer	0.00088	0.000901	CcSEcCtD
Nalbuphine—Pruritus—Epirubicin—urinary bladder cancer	0.000868	0.000888	CcSEcCtD
Nalbuphine—Dizziness—Methotrexate—urinary bladder cancer	0.000867	0.000887	CcSEcCtD
Nalbuphine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000836	0.000856	CcSEcCtD
Nalbuphine—Vomiting—Methotrexate—urinary bladder cancer	0.000833	0.000853	CcSEcCtD
Nalbuphine—Rash—Methotrexate—urinary bladder cancer	0.000827	0.000846	CcSEcCtD
Nalbuphine—Dermatitis—Methotrexate—urinary bladder cancer	0.000826	0.000845	CcSEcCtD
Nalbuphine—Headache—Methotrexate—urinary bladder cancer	0.000821	0.000841	CcSEcCtD
Nalbuphine—Asthenia—Doxorubicin—urinary bladder cancer	0.000814	0.000834	CcSEcCtD
Nalbuphine—Dizziness—Epirubicin—urinary bladder cancer	0.000811	0.00083	CcSEcCtD
Nalbuphine—Pruritus—Doxorubicin—urinary bladder cancer	0.000803	0.000822	CcSEcCtD
Nalbuphine—Vomiting—Epirubicin—urinary bladder cancer	0.00078	0.000798	CcSEcCtD
Nalbuphine—Nausea—Methotrexate—urinary bladder cancer	0.000779	0.000797	CcSEcCtD
Nalbuphine—Rash—Epirubicin—urinary bladder cancer	0.000773	0.000792	CcSEcCtD
Nalbuphine—Dermatitis—Epirubicin—urinary bladder cancer	0.000773	0.000791	CcSEcCtD
Nalbuphine—Headache—Epirubicin—urinary bladder cancer	0.000768	0.000787	CcSEcCtD
Nalbuphine—Dizziness—Doxorubicin—urinary bladder cancer	0.000751	0.000768	CcSEcCtD
Nalbuphine—Nausea—Epirubicin—urinary bladder cancer	0.000729	0.000746	CcSEcCtD
Nalbuphine—Vomiting—Doxorubicin—urinary bladder cancer	0.000722	0.000739	CcSEcCtD
Nalbuphine—Rash—Doxorubicin—urinary bladder cancer	0.000716	0.000733	CcSEcCtD
Nalbuphine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000715	0.000732	CcSEcCtD
Nalbuphine—Headache—Doxorubicin—urinary bladder cancer	0.000711	0.000728	CcSEcCtD
Nalbuphine—Nausea—Doxorubicin—urinary bladder cancer	0.000674	0.00069	CcSEcCtD
